ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,440.00
2.13%
다우존스 지수
38,675.68
1.18%
Bitcoin
62,699.23
6.05%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. ALX Oncology Holdings Inc (ALXO)

  7. ALX Oncology Holdings Inc (ALXO) 뉴스

ALXO ALX Oncology Holdings Inc

15.36
-1.26 (-7.58%)
시간외 거래
최종 업데이트: 05:46:57
15분 지연
기업명 주식 심볼 시장 주식 타입
ALX Oncology Holdings Inc ALXO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-1.26 -7.58% 15.36 05:46:57
개장가 저가 고가 종가 전일 종가
16.92 15.2144 17.13 15.36 16.62
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202422:00GLOBEALX Oncology Announces Initiation of Phase 2..
24/04/202423:00GLOBEALX Oncology Announces Two Evorpacept Abstracts Accepted for..
10/04/202406:30GLOBEALX Oncology Reports Encouraging Clinical Data of Evorpacept..
08/03/202406:05EDGAR2Form 8-K - Current report
08/03/202406:03GLOBEALX Oncology Reports Fourth Quarter and Full Year 2023..
06/03/202406:30GLOBEALX Oncology Announces Two Evorpacept Clinical Abstracts..
17/02/202408:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202408:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202408:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202422:00GLOBEALX Oncology to Present at the 42nd Annual J.P. Morgan..
27/12/202306:01EDGAR2Form 8-K - Current report
14/11/202306:05GLOBEALX Oncology Reports Third Quarter 2023 Financial Results..
14/11/202306:03EDGAR2Form 8-K - Current report
02/11/202305:05GLOBEALX Oncology Announces November Investor Conference..
11/10/202305:05GLOBEALX Oncology Announces Closing of Public Offering, Including..
06/10/202319:06EDGAR2Form 8-K - Current report
06/10/202319:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/10/202321:00GLOBEALX Oncology Announces Pricing of Public Offering
05/10/202306:21EDGAR2Form 8-K - Current report
05/10/202306:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/10/202305:10GLOBEALX Oncology Announces Proposed Public Offering
04/10/202321:00EDGAR2Form 8-K - Current report
03/10/202323:03IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
03/10/202319:00GLOBEALX Oncology Reports Positive Interim Phase 2 ASPEN-06..
03/10/202305:05GLOBEALX Oncology to Host Investor Call and Webcast on October 3,..
20/09/202321:45IHNWPathways to Progress: How Orphan Drug Designation Sparks..
11/09/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
09/09/202305:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/09/202305:05EDGAR2Form 8-K - Current report
06/09/202321:00GLOBEALX Oncology Realigns Executive Leadership Team
02/09/202305:11EDGAR2Form S-3 - Registration statement under Securities Act of..
31/08/202320:00GLOBEALX Oncology Announces September Investor Conference..
26/08/202305:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/08/202305:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:05EDGAR2Form 8-K - Current report
11/08/202305:01GLOBEALX Oncology Reports Second Quarter 2023 Financial Results..
28/07/202305:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/07/202305:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/07/202305:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/07/202305:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202306:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/06/202320:00GLOBEALX Oncology Receives Orphan Drug Designation from the..
12/05/202305:01GLOBEALX Oncology Reports First Quarter 2023 Financial Results..
09/05/202320:00GLOBEALX Oncology Announces First Patient Dosed in Phase 2..

최근 히스토리

NASDAQ
ALXO
ALX Oncology
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유